COMPARTMENTAL MODELING APPROACH OF LOSARTAN TRANSDERMAL TRANSPORT IN VITRO

Development of losartan in transdermal formulation is important due to its low oral bioavailability. Optimal transdermal formulation requires transport mechanism understanding. This study was aimed to develop and evaluate compartmental modeling of losartan transdermal transport in vitro to fulfi...

Full description

Bibliographic Details
Main Authors: Akhmad Kharis Nugroho, Annas Binnarjo, Arief Rahman Hakim, Yunita Ermawati
Format: Article
Language:English
Published: Universitas Gadjah Mada 2014-01-01
Series:Indonesian Journal of Pharmacy
Subjects:
Online Access:http://indonesianjpharm.farmasi.ugm.ac.id/index.php/3/article/view/16
id doaj-00e9888542d1480493060e1841c7ea7a
record_format Article
spelling doaj-00e9888542d1480493060e1841c7ea7a2020-11-25T00:46:26ZengUniversitas Gadjah MadaIndonesian Journal of Pharmacy2338-94272338-94862014-01-01251313810.14499/indonesianjpharm25iss1pp31COMPARTMENTAL MODELING APPROACH OF LOSARTAN TRANSDERMAL TRANSPORT IN VITROAkhmad Kharis Nugroho0Annas Binnarjo1Arief Rahman Hakim2Yunita Ermawati3Faculty of Pharmacy Universitas Gadjah Mada, Sekip Utara Yogyakarta, 55281 IndonesiaFaculty of Pharmacy Universitas Gadjah Mada, Sekip Utara Yogyakarta, 55281 IndonesiaFaculty of Pharmacy Universitas Gadjah Mada, Sekip Utara Yogyakarta, 55281 IndonesiaFaculty of Pharmacy Universitas Gadjah Mada, Sekip Utara Yogyakarta, 55281 IndonesiaDevelopment of losartan in transdermal formulation is important due to its low oral bioavailability. Optimal transdermal formulation requires transport mechanism understanding. This study was aimed to develop and evaluate compartmental modeling of losartan transdermal transport in vitro to fulfil this demand. Losartan solution (10g/L in 20% propylene glycol) was filled into the acceptor phase of a vertical diffusion-cells system. The fresh rat skin (pretreated with oleic acid for 1 hour) was used as the transport membrane separating the donor and the acceptor phase, which was filled with phosphate-buffered-saline pH 7.4. During 30h, samples were collected and analyzed using HPLC method. Four compartmental models were proposed, i.e. models with one (model 1) or two (model 2) lag-compartment(s) either with a zero-order (model A) or a first- order (model B) drug input from donor to the skin. WinSAAM was used to evaluate the models based on the parameters: 1) visual goodness of fit (GOF); and 2) Corrected Akaike's Information Criterion (AICc). Both the GOF and AICc evaluations indicated model 2-A as the best model describing losartan transdermal transport. The model suggested that after reaching the upper layer of skin at a constant rate, losartan transport was split into two flows. Both flows are transited in two separate lagcompartments before reaching into the acceptor phase. http://indonesianjpharm.farmasi.ugm.ac.id/index.php/3/article/view/16TransdermalLosartanModelingLag-compartmentWinSAAM
collection DOAJ
language English
format Article
sources DOAJ
author Akhmad Kharis Nugroho
Annas Binnarjo
Arief Rahman Hakim
Yunita Ermawati
spellingShingle Akhmad Kharis Nugroho
Annas Binnarjo
Arief Rahman Hakim
Yunita Ermawati
COMPARTMENTAL MODELING APPROACH OF LOSARTAN TRANSDERMAL TRANSPORT IN VITRO
Indonesian Journal of Pharmacy
Transdermal
Losartan
Modeling
Lag-compartment
WinSAAM
author_facet Akhmad Kharis Nugroho
Annas Binnarjo
Arief Rahman Hakim
Yunita Ermawati
author_sort Akhmad Kharis Nugroho
title COMPARTMENTAL MODELING APPROACH OF LOSARTAN TRANSDERMAL TRANSPORT IN VITRO
title_short COMPARTMENTAL MODELING APPROACH OF LOSARTAN TRANSDERMAL TRANSPORT IN VITRO
title_full COMPARTMENTAL MODELING APPROACH OF LOSARTAN TRANSDERMAL TRANSPORT IN VITRO
title_fullStr COMPARTMENTAL MODELING APPROACH OF LOSARTAN TRANSDERMAL TRANSPORT IN VITRO
title_full_unstemmed COMPARTMENTAL MODELING APPROACH OF LOSARTAN TRANSDERMAL TRANSPORT IN VITRO
title_sort compartmental modeling approach of losartan transdermal transport in vitro
publisher Universitas Gadjah Mada
series Indonesian Journal of Pharmacy
issn 2338-9427
2338-9486
publishDate 2014-01-01
description Development of losartan in transdermal formulation is important due to its low oral bioavailability. Optimal transdermal formulation requires transport mechanism understanding. This study was aimed to develop and evaluate compartmental modeling of losartan transdermal transport in vitro to fulfil this demand. Losartan solution (10g/L in 20% propylene glycol) was filled into the acceptor phase of a vertical diffusion-cells system. The fresh rat skin (pretreated with oleic acid for 1 hour) was used as the transport membrane separating the donor and the acceptor phase, which was filled with phosphate-buffered-saline pH 7.4. During 30h, samples were collected and analyzed using HPLC method. Four compartmental models were proposed, i.e. models with one (model 1) or two (model 2) lag-compartment(s) either with a zero-order (model A) or a first- order (model B) drug input from donor to the skin. WinSAAM was used to evaluate the models based on the parameters: 1) visual goodness of fit (GOF); and 2) Corrected Akaike's Information Criterion (AICc). Both the GOF and AICc evaluations indicated model 2-A as the best model describing losartan transdermal transport. The model suggested that after reaching the upper layer of skin at a constant rate, losartan transport was split into two flows. Both flows are transited in two separate lagcompartments before reaching into the acceptor phase.
topic Transdermal
Losartan
Modeling
Lag-compartment
WinSAAM
url http://indonesianjpharm.farmasi.ugm.ac.id/index.php/3/article/view/16
work_keys_str_mv AT akhmadkharisnugroho compartmentalmodelingapproachoflosartantransdermaltransportinvitro
AT annasbinnarjo compartmentalmodelingapproachoflosartantransdermaltransportinvitro
AT ariefrahmanhakim compartmentalmodelingapproachoflosartantransdermaltransportinvitro
AT yunitaermawati compartmentalmodelingapproachoflosartantransdermaltransportinvitro
_version_ 1725265486354055168